v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities      
Net loss $ (61,982) $ (444,116) $ (11,079)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Goodwill impairment 386,154
Impairment of other long-lived assets 1,447 6,985 776
Depreciation and amortization 56,096 49,560 50,942
Stock-based compensation 30,977 20,204 20,564
Foreign currency transaction loss (gain) 3,446 (8,718) (1,900)
Gain from sale of investments (3,578)
Gain from step acquisition (14,400)
Share in (profits) losses of associated companies (949) 3,939 412
Revaluation of investments (1,301)
Other non-cash items, net 2,914 (2,552) (103)
Change in cash attributable to changes in operating assets and liabilities:      
Accounts receivable, net (25,003) 29,465 4,967
Inventories (53) 37,120 (48,647)
Other current assets and prepaid expenses (14,976) 10,147 (2,936)
Other non-current assets 4,465 (1,040) 5,807
Accounts payable 28,492 (24,534) (13,114)
Other current liabilities 41,393 (10,033) (7,273)
Deferred revenues 8,872 (6,398) (3,779)
Deferred income taxes, net and uncertain tax positions (12,380) (20,299) 3,161
Other non-current liabilities (11,234) 1,918 (5,413)
Net cash provided by (used in) operating activities 35,824 27,802 (11,193)
Cash flows from investing activities      
Cash paid for business combinations, net of cash acquired (20,553) (29,115)
Purchase of property and equipment (24,981) (26,943) (22,420)
Investments in short-term bank deposits (361,000) (27,000) (28,300)
Proceeds from short-term bank deposits 129,000 28,300
Proceeds from sale of equity method investment 3,175
Net proceeds from divestitures of subsidiaries and associated companies 1,000 4,909
Investments in non-marketable equity securities (11,779)
Purchase of intangible assets (1,770) (2,070) (2,752)
Other investing activities (82) 28 (20,963)
Net cash used in investing activities (291,165) (52,625) (69,526)
Cash flows from financing activities      
Proceeds from public offering, net of issuance costs 218,850
Proceeds from exercise of stock options 8,055 228 5,284
Repayment of bank loan (27,293)
Other financing activities 406
Net cash provided by (used in) financing activities 227,311 228 (22,009)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (893) 3,214 2,591
Net change in cash, cash equivalents and restricted cash (28,923) (21,381) (100,137)
Cash, cash equivalents and restricted cash, beginning of year 272,216 293,597 393,734
Cash, cash equivalents and restricted cash, end of year 243,293 272,216 293,597
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:      
Cash and cash equivalents 243,179 272,092 293,484
Restricted cash included in other current assets 114 124 113
Total cash, cash equivalents and restricted cash shown in the statement of cash flows 243,293 272,216 293,597
Cash paid during the year for:      
Income taxes, net of tax refunds 2,418 1,140 10,730
Interest 449
Non-cash investing activities:      
Transfer of inventories to fixed assets 2,673 4,138 3,307
Transfer of fixed assets to inventories 977 410 322
Contingent consideration 17,985 37,400
Issuance of shares as part of Origin acquisition (Refer to Note 2) $ 26,636

Source